Skip to main content
Top
Published in: Annals of General Psychiatry 1/2012

Open Access 01-12-2012 | Primary research

Does duration of untreated psychosis predict very long term outcome of schizophrenic disorders? results of a retrospective study

Authors: Diego Primavera, Chiara Bandecchi, Tiziana Lepori, Lucia Sanna, Eraldo Nicotra, Bernardo Carpiniello

Published in: Annals of General Psychiatry | Issue 1/2012

Login to get access

Abstract

Background

Studies performed to assess the relevance of duration of untreated psychosis (DUP) as a predictor of long-term outcome (i.e. follow-ups of ten years or more) are somewhat limited. The aim of this study was to evaluate the potential association between DUP and very long-term outcome (16-33 yrs) of schizophrenia by means of a retrospective design.

Methods

Retrospective data obtained from clinical records were collected regarding DUP and outcome variables (number of hospitalizations; number of attempted suicides; course of illness; GAF scores at last observation) for a cohort of 80 outpatients (52 Males, 28 Females, mean age 51.0+/-11.58 years) affected by schizophrenia according to DSMIVTR attending a university community mental health centre.

Results

Mean duration of follow up was 25.2 +/- 8.68 years; mean duration of untreated psychosis was 49.00 months (range 1-312 mo), with no significant difference according to gender. Patients with a shorter DUP (=/< 1 year) displayed more frequent “favourable” courses of illness (28.9% vs 8.6%) (p = 0.025), more frequent cases with limited (=/< 3) number of hospital admissions (85.7% vs 62.1%) (p = 0.047) and a better functioning (mean GAF score = 50.32+/-16.49 vs 40.26+/-9.60, p = 0.002); regression analyses confirmed that shorter DUP independently predicted a more positive outcome in terms of number of hospital admissions, course of illness, functioning (GAF scores).

Conclusion

A shorter DUP appears to act as a significant predictor of better outcome in schizophrenia even in the very long-term.
Literature
1.
go back to reference Lambert M, Karow A, Leucht S, Schimmelmann BG, Naber D: Remission in schizophrenia: validity, frequency, predictors, and patient’s perspective 5 years later. Dialogues Clin Neurosci. 2010, 12: 393-407.PubMedCentralPubMed Lambert M, Karow A, Leucht S, Schimmelmann BG, Naber D: Remission in schizophrenia: validity, frequency, predictors, and patient’s perspective 5 years later. Dialogues Clin Neurosci. 2010, 12: 393-407.PubMedCentralPubMed
2.
go back to reference Warner M: Recovery from schizophrenia and the recovery model. Curr Opin Psychiatry. 2009, 22: 374-380. 10.1097/YCO.0b013e32832c920b.CrossRefPubMed Warner M: Recovery from schizophrenia and the recovery model. Curr Opin Psychiatry. 2009, 22: 374-380. 10.1097/YCO.0b013e32832c920b.CrossRefPubMed
3.
go back to reference Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T: Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiat. 2005, 63: 975-983.CrossRef Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T: Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiat. 2005, 63: 975-983.CrossRef
4.
go back to reference Perkins DO, Gu H, Boteva K, Lieberman JA: Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am. J. Psychiat. 2005, 162: 1785-1804. 10.1176/appi.ajp.162.10.1785.CrossRefPubMed Perkins DO, Gu H, Boteva K, Lieberman JA: Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am. J. Psychiat. 2005, 162: 1785-1804. 10.1176/appi.ajp.162.10.1785.CrossRefPubMed
5.
go back to reference Keshavan MS, Amirsadri A: Early intervention in schizophrenia: current and future perspectives. Curr Psychiatry Rep. 2007, 9: 325-328. 10.1007/s11920-007-0040-8.CrossRefPubMed Keshavan MS, Amirsadri A: Early intervention in schizophrenia: current and future perspectives. Curr Psychiatry Rep. 2007, 9: 325-328. 10.1007/s11920-007-0040-8.CrossRefPubMed
6.
go back to reference Marshall M, Rathbone J: Early intervention for psychosis. Cochrane Database Syst Rev. 2011, 15 (6): CD004718 - Marshall M, Rathbone J: Early intervention for psychosis. Cochrane Database Syst Rev. 2011, 15 (6): CD004718 -
7.
go back to reference Carbone S, Harrigan S, McGorry PD, Curry C, Elkins K: Duration of untreated psychosis and 12-month outcome in first-episode psychosis: the impact of treatment approach. Acta Psychiatr Scand. 1999, 100: 96-104. 10.1111/j.1600-0447.1999.tb10830.x.CrossRefPubMed Carbone S, Harrigan S, McGorry PD, Curry C, Elkins K: Duration of untreated psychosis and 12-month outcome in first-episode psychosis: the impact of treatment approach. Acta Psychiatr Scand. 1999, 100: 96-104. 10.1111/j.1600-0447.1999.tb10830.x.CrossRefPubMed
8.
go back to reference Larsen TK, McGlashan TH, Moe LC: First-episode schizophrenia: Early course parameters. Schizophr Bull. 1996, 22: 241-256. 10.1093/schbul/22.2.241.CrossRefPubMed Larsen TK, McGlashan TH, Moe LC: First-episode schizophrenia: Early course parameters. Schizophr Bull. 1996, 22: 241-256. 10.1093/schbul/22.2.241.CrossRefPubMed
9.
go back to reference McGlashan TH: Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course? . Biol Psychiatry. 1999, 46: 899-907. 10.1016/S0006-3223(99)00084-0.CrossRefPubMed McGlashan TH: Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course? . Biol Psychiatry. 1999, 46: 899-907. 10.1016/S0006-3223(99)00084-0.CrossRefPubMed
10.
go back to reference Bottlender R, Strauss A, Moller H: Impact of duration of symptoms prior to first hospitalization on acute outcome in 998 schizophrenic patients. Schizophr Res. 2000, 44: 145-150. 10.1016/S0920-9964(99)00186-3.CrossRefPubMed Bottlender R, Strauss A, Moller H: Impact of duration of symptoms prior to first hospitalization on acute outcome in 998 schizophrenic patients. Schizophr Res. 2000, 44: 145-150. 10.1016/S0920-9964(99)00186-3.CrossRefPubMed
11.
go back to reference Drake RJ, Haley CJ, Akhtar S, Lewis SW: Causes and consequences of duration of untreated psychosis in schizophrenia. Brit Journ Psychiat. 2000, 177: 511-515. 10.1192/bjp.177.6.511.CrossRef Drake RJ, Haley CJ, Akhtar S, Lewis SW: Causes and consequences of duration of untreated psychosis in schizophrenia. Brit Journ Psychiat. 2000, 177: 511-515. 10.1192/bjp.177.6.511.CrossRef
12.
go back to reference Scully PJ, Coakley G, Kinsella A, Waddington JL: Psychopathology, executive (frontal) and general cognitive impairment in relation to duration of initially untreated versus subsequently treated psychosis in chronic schizophrenia. Psychol Med. 1997, 27: 1303-1310. 10.1017/S0033291797005722.CrossRefPubMed Scully PJ, Coakley G, Kinsella A, Waddington JL: Psychopathology, executive (frontal) and general cognitive impairment in relation to duration of initially untreated versus subsequently treated psychosis in chronic schizophrenia. Psychol Med. 1997, 27: 1303-1310. 10.1017/S0033291797005722.CrossRefPubMed
13.
go back to reference Huber G: The heterogeneous course of schizophrenia. Schizophr Res. 1997, 28: 177-185. 10.1016/S0920-9964(97)00113-8.CrossRefPubMed Huber G: The heterogeneous course of schizophrenia. Schizophr Res. 1997, 28: 177-185. 10.1016/S0920-9964(97)00113-8.CrossRefPubMed
14.
go back to reference Wiersma D, Nienhuis FJ, Sloof CJ, Giel R: Natural course of schizophrenic disorders: a 15-years follow-up of a Dutch incidence cohort. Schizophr Bull. 1998, 24: 75-85. 10.1093/oxfordjournals.schbul.a033315.CrossRefPubMed Wiersma D, Nienhuis FJ, Sloof CJ, Giel R: Natural course of schizophrenic disorders: a 15-years follow-up of a Dutch incidence cohort. Schizophr Bull. 1998, 24: 75-85. 10.1093/oxfordjournals.schbul.a033315.CrossRefPubMed
15.
go back to reference Wiersma D, Wanderling J, Dragomirecka E, Ganev K, Harrison G, An Der Heiden W, Nienhuis FJ, Walsh D: Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centres. Psychol Med. 2000, 30: 1155-1167. 10.1017/S0033291799002627.CrossRefPubMed Wiersma D, Wanderling J, Dragomirecka E, Ganev K, Harrison G, An Der Heiden W, Nienhuis FJ, Walsh D: Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centres. Psychol Med. 2000, 30: 1155-1167. 10.1017/S0033291799002627.CrossRefPubMed
16.
go back to reference Bottlender R, Sato T, Jäger M, Wegener U, Wittmann J, Strauss A, Möller HJ: The impact of the duration of untreated psychosis prior to first psychiatric admission on the 15-year outcome in schizophrenia. Schizophr Res. 2003, 62: 37-44. 10.1016/S0920-9964(02)00348-1.CrossRefPubMed Bottlender R, Sato T, Jäger M, Wegener U, Wittmann J, Strauss A, Möller HJ: The impact of the duration of untreated psychosis prior to first psychiatric admission on the 15-year outcome in schizophrenia. Schizophr Res. 2003, 62: 37-44. 10.1016/S0920-9964(02)00348-1.CrossRefPubMed
17.
go back to reference Hua J, Wong KE, Kua EH, Tsoi WF: A 20-year follow-up on schizophrenia in Singaphore. Acta Psych Scand. 2003, 108: 118-125. 10.1034/j.1600-0447.2003.00107.x.CrossRef Hua J, Wong KE, Kua EH, Tsoi WF: A 20-year follow-up on schizophrenia in Singaphore. Acta Psych Scand. 2003, 108: 118-125. 10.1034/j.1600-0447.2003.00107.x.CrossRef
18.
go back to reference American Psychiatric Association: Diagnostic and Statistical Manual for Mewntal Duisodres. 2000, American Psychiatric Association, Washington DC, Fourt Edition American Psychiatric Association: Diagnostic and Statistical Manual for Mewntal Duisodres. 2000, American Psychiatric Association, Washington DC, Fourt Edition
19.
go back to reference First MB, Spitzer RL, Williams JBW, Gibbon M: Structured Clinical Interview for DSM IV Axis I Disorders – Research Version (SCID I, Version 2.0). 1996, Biometrics Research Department, Sate Psychiatric Institute, New York First MB, Spitzer RL, Williams JBW, Gibbon M: Structured Clinical Interview for DSM IV Axis I Disorders – Research Version (SCID I, Version 2.0). 1996, Biometrics Research Department, Sate Psychiatric Institute, New York
20.
go back to reference Carpiniello B, Baita A, Carta MG, Sitzia R, Macciardi AM, Murgia S, Altamura AC: Clinical and Psychosocial outcome of patients affected by panic disorder with or without agorafobia: result of a naturalistic follow-up study. Eur Psych. 2002, 17: 394-398. 10.1016/S0924-9338(02)00701-0.CrossRef Carpiniello B, Baita A, Carta MG, Sitzia R, Macciardi AM, Murgia S, Altamura AC: Clinical and Psychosocial outcome of patients affected by panic disorder with or without agorafobia: result of a naturalistic follow-up study. Eur Psych. 2002, 17: 394-398. 10.1016/S0924-9338(02)00701-0.CrossRef
21.
go back to reference Conti L, Dell’Osso L, Cassano GB: Il sistema AMDP. Manuale per la valutazione e la Documentazione della Psicopatologia. 1988, Versione Italiana, Milano: Mazzuchelli Conti L, Dell’Osso L, Cassano GB: Il sistema AMDP. Manuale per la valutazione e la Documentazione della Psicopatologia. 1988, Versione Italiana, Milano: Mazzuchelli
22.
go back to reference American Psychiatric Association: Global Assessment of Functioning Scale (GAF). 1994, American Psychiatric Association. American Psychiatric Press, Washington, DC, 32-Fourth edition (DSM-IV) American Psychiatric Association: Global Assessment of Functioning Scale (GAF). 1994, American Psychiatric Association. American Psychiatric Press, Washington, DC, 32-Fourth edition (DSM-IV)
23.
go back to reference Szymanski S, Lieberman JA, Alvir JM, Mayerhoff D, Loebel A: Geisler S, Chakos M, Jody, D, Kane, J: Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. Am Journ Psychiat. 1995, 152: 698-703.CrossRef Szymanski S, Lieberman JA, Alvir JM, Mayerhoff D, Loebel A: Geisler S, Chakos M, Jody, D, Kane, J: Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. Am Journ Psychiat. 1995, 152: 698-703.CrossRef
24.
go back to reference Altamura AC, Bassetti R, Sassella F, Salvatori D, Mundo E: Duration of Untreated Psychosis as a predictor of outcome in first episode schizophrenia: a retrospective study. Schizophr Res. 2001, 52: 29-36. 10.1016/S0920-9964(00)00187-0.CrossRefPubMed Altamura AC, Bassetti R, Sassella F, Salvatori D, Mundo E: Duration of Untreated Psychosis as a predictor of outcome in first episode schizophrenia: a retrospective study. Schizophr Res. 2001, 52: 29-36. 10.1016/S0920-9964(00)00187-0.CrossRefPubMed
25.
go back to reference Harris MG, Henry LP, Harrigan SM, Purcell R, Schwartz OS, Farrely SE, Prosser AL, Jackson HJ, McGorry PD: The relationship between duration of untreated psychosis and outcome: An eight-year prospective study. Schizophr Res. 2005, 79: 85-93. 10.1016/j.schres.2005.05.024.CrossRefPubMed Harris MG, Henry LP, Harrigan SM, Purcell R, Schwartz OS, Farrely SE, Prosser AL, Jackson HJ, McGorry PD: The relationship between duration of untreated psychosis and outcome: An eight-year prospective study. Schizophr Res. 2005, 79: 85-93. 10.1016/j.schres.2005.05.024.CrossRefPubMed
26.
go back to reference Falloon IR, Kydd RR, Coverdale JH, Laidlaw TM: Early detection and intervention for initial episodes of schizophrenia. Schizophr Bull. 1996, 22: 271-282. 10.1093/schbul/22.2.271.CrossRefPubMed Falloon IR, Kydd RR, Coverdale JH, Laidlaw TM: Early detection and intervention for initial episodes of schizophrenia. Schizophr Bull. 1996, 22: 271-282. 10.1093/schbul/22.2.271.CrossRefPubMed
27.
go back to reference De Quardo JR: Pharmacologic treatment of first-episode schizophrenia: early intervention is the key to the outcome. Journ Clin Psych. 1998, 59: 9-17. De Quardo JR: Pharmacologic treatment of first-episode schizophrenia: early intervention is the key to the outcome. Journ Clin Psych. 1998, 59: 9-17.
28.
go back to reference Altamura AC, Camuri G, Dell’Osso B: Understanding the role of the duration of untreated illness in psychiatric disorders: a narrative review. Riv Psichiatr. 2010, 45: 197-208.PubMed Altamura AC, Camuri G, Dell’Osso B: Understanding the role of the duration of untreated illness in psychiatric disorders: a narrative review. Riv Psichiatr. 2010, 45: 197-208.PubMed
29.
go back to reference Singh SP: Outcome measures in early psychosis: relevance of duration of untreated psychosis. Brit J Psych. 2007, 50: S58-S63.CrossRef Singh SP: Outcome measures in early psychosis: relevance of duration of untreated psychosis. Brit J Psych. 2007, 50: S58-S63.CrossRef
30.
go back to reference Emsley R, Chiliza B, Schoemann R: Predictors of long term outcome in schizophrenia. Curr Opin Psychiat. 2008, 21: 173-177. 10.1097/YCO.0b013e3282f33f76.CrossRef Emsley R, Chiliza B, Schoemann R: Predictors of long term outcome in schizophrenia. Curr Opin Psychiat. 2008, 21: 173-177. 10.1097/YCO.0b013e3282f33f76.CrossRef
31.
go back to reference White C, Stirling J, Hopkins R, Morris J, Montague L, Tantam D, Lewis S: Predictors of 10-year outcome of first-episode psychosis. Psychol Med. 2009, 39: 1447-1456. 10.1017/S003329170800514X.CrossRefPubMed White C, Stirling J, Hopkins R, Morris J, Montague L, Tantam D, Lewis S: Predictors of 10-year outcome of first-episode psychosis. Psychol Med. 2009, 39: 1447-1456. 10.1017/S003329170800514X.CrossRefPubMed
32.
go back to reference Cechnicki A, Hanuszkiewicz I, Polczyk R, Bielańska A: Prognostic value of duration of untreated psychosis in long-term outcome of schizophrenia. Med Sci Monit. 2011, 17: CR277-CR283.PubMedCentralCrossRefPubMed Cechnicki A, Hanuszkiewicz I, Polczyk R, Bielańska A: Prognostic value of duration of untreated psychosis in long-term outcome of schizophrenia. Med Sci Monit. 2011, 17: CR277-CR283.PubMedCentralCrossRefPubMed
33.
go back to reference Röpcke B, Eggers C: Early-onset schizophrenia: a 15-year follow-up. Eur J Child Adol Psych. 2005, 14: 341-501. 10.1007/s00787-005-0483-6.CrossRef Röpcke B, Eggers C: Early-onset schizophrenia: a 15-year follow-up. Eur J Child Adol Psych. 2005, 14: 341-501. 10.1007/s00787-005-0483-6.CrossRef
34.
go back to reference de Haan L, van Der Gaag M, Wolthaus J: Duration of untreated psychosis and the long-term course of schizophrenia. Eur Psychiat. 2000, 15: 264-267. 10.1016/S0924-9338(00)00234-0.CrossRef de Haan L, van Der Gaag M, Wolthaus J: Duration of untreated psychosis and the long-term course of schizophrenia. Eur Psychiat. 2000, 15: 264-267. 10.1016/S0924-9338(00)00234-0.CrossRef
35.
go back to reference Shrivastava A, Shah N, Johnston M, Stitt L, Thakar M, Chinnasamy G: Effects of duration of untreated psychosis on long-term outcome of people hospitalized with first episode schizophrenia. Ind J Psychiat. 2010, 52: 164-167. 10.4103/0019-5545.64583.CrossRef Shrivastava A, Shah N, Johnston M, Stitt L, Thakar M, Chinnasamy G: Effects of duration of untreated psychosis on long-term outcome of people hospitalized with first episode schizophrenia. Ind J Psychiat. 2010, 52: 164-167. 10.4103/0019-5545.64583.CrossRef
36.
go back to reference Volz HP: Successfully treating acutely ill patients: does it improve long-term outcome in psychiatric disorders?. BMC Psychiat. 2007, 7 (1): S70-10.1186/1471-244X-7-S1-S70.CrossRef Volz HP: Successfully treating acutely ill patients: does it improve long-term outcome in psychiatric disorders?. BMC Psychiat. 2007, 7 (1): S70-10.1186/1471-244X-7-S1-S70.CrossRef
Metadata
Title
Does duration of untreated psychosis predict very long term outcome of schizophrenic disorders? results of a retrospective study
Authors
Diego Primavera
Chiara Bandecchi
Tiziana Lepori
Lucia Sanna
Eraldo Nicotra
Bernardo Carpiniello
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Annals of General Psychiatry / Issue 1/2012
Electronic ISSN: 1744-859X
DOI
https://doi.org/10.1186/1744-859X-11-21

Other articles of this Issue 1/2012

Annals of General Psychiatry 1/2012 Go to the issue